CLEAR Care Companion Application

Last updated: January 7, 2025
Sponsor: University of Michigan Rogel Cancer Center
Overall Status: Completed

Phase

N/A

Condition

Bladder Cancer

Urothelial Cancer

Urothelial Carcinoma

Treatment

CLEAR Care Companion (CC) application

Clinical Study ID

NCT05578898
UMCC 2021.077
HUM00201652
  • Ages > 18
  • All Genders

Study Summary

Hospital readmissions are common after major cancer surgery, leading to poorer patient outcomes, increased mortality and additional costs. In this study, Clinical and Engineering Approaches to Readmission (CLEAR) Care Companion Application, investigators aim to utilize a smartphone application that tracks concerning postoperative symptoms and provides educational interventions to determine if this can minimize delays in communication between patients and medical providers, increase patient satisfaction with the care received, and reduce or lessen the severity of readmissions.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients undergoing a radical cystectomy with reconstruction through GU OncologyClinic

  • Patient at the University of Michigan (Michigan Medicine)

  • Access to compatible smartphone or tablet device

Exclusion

Exclusion Criteria:

  • Non-English speaking patients

  • Patients without access to a smart phone or tablet with internet capacity

Study Design

Total Participants: 28
Treatment Group(s): 1
Primary Treatment: CLEAR Care Companion (CC) application
Phase:
Study Start date:
August 12, 2022
Estimated Completion Date:
July 24, 2024

Study Description

Patients complete clinically meaningful questions and validated questionnaires pertaining to physiological and psychological symptoms that serve as early indicators of readmission, with the aim to improve experience by empowering patient to be active participants in their recovery, identify complications early to minimize morbidity and reduce overall readmissions.

The study has the following three objectives: (1) Assess patient engagement with the CLEAR Care Companion application for patients that have undergone radical cystectomy (2) Measure patient experience with the application and its effect on satisfaction with overall care (3) Evaluate the effect of the application on case complexity (readmission intensity) and overall readmission rates.

Connect with a study center

  • University of Michigan Rogel Cancer Center

    Ann Arbor, Michigan 48109
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.